{"id":607612,"date":"2026-02-22T07:18:27","date_gmt":"2026-02-22T07:18:27","guid":{"rendered":"https:\/\/www.europesays.com\/us\/607612\/"},"modified":"2026-02-22T07:18:27","modified_gmt":"2026-02-22T07:18:27","slug":"ips-cell-based-products-win-conditional-approval-from-health-ministry-panel","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/607612\/","title":{"rendered":"iPS cell-based products win conditional approval from health ministry panel"},"content":{"rendered":"<p>A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the way for the world\u2019s first commercialization of Nobel Prize-winning stem cell research.<\/p>\n<p>But Thursday\u2019s endorsement of the products \u2014 neurons for Parkinson\u2019s disease and muscle patches for severe heart disease \u2014 was based on small-scale clinical studies that confirmed only their safety and \u201cpresumed\u201d their efficacy.<\/p>\n<p>The manufacturers must conduct postmarket clinical trials to see if they actually work. If the efficacy is not fully proven, the ministry will withdraw approval within seven years.<\/p>\n","protected":false},"excerpt":{"rendered":"A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the&hellip;\n","protected":false},"author":3,"featured_media":607613,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[210,1141,1142,255367,26027,67,132,68],"class_list":{"0":"post-607612","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-care","8":"tag-health","9":"tag-health-care","10":"tag-healthcare","11":"tag-ips","12":"tag-parkinson","13":"tag-united-states","14":"tag-unitedstates","15":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116113067517985609","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/607612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=607612"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/607612\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/607613"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=607612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=607612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=607612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}